PARDES BIOSCIENCES

Pardes Biosciences is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. The company’s lead product candidate, PBI-0451, is being developed as a direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections, the virus responsible for COVID-19. Pardes Biosciences is on a mission to stop a pandemic and start a movement so patients everywhere can get well sooner.

#SimilarOrganizations #People #Financial #Event #Website #More

PARDES BIOSCIENCES

Social Links:

Industry:

Biotechnology Life Science

Founded:

2020-01-01

Address:

Carlsbad, California, United States

Country:

United States

Website Url:

http://www.pardesbio.com

Total Employee:

Status:

Active

Contact:

415-649-8758

Total Funding:

126.61 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Mobile Non Scaleable Content

Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

eureka-therapeutics-logo

Eureka Therapeutics

Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

seismic-therapeutic-logo

Seismic Therapeutic

Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

walden-biosciences-logo

Walden Biosciences

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.

Current Advisors List

thomas-g-wiggans_image

Thomas G. Wiggans Chairman of the Board @ Pardes Biosciences
Board_member
2022-03-01

Current Employees Featured

not_available_image

Philippe Tinmouth
Philippe Tinmouth Chief Business and Strategy Officer @ Pardes Biosciences
Chief Business and Strategy Officer
2021-11-01

uri-lopatin_image

Uri Lopatin
Uri Lopatin Founder, President, Chief Executive Officer @ Pardes Biosciences
Founder, President, Chief Executive Officer

thomas-g-wiggans_image

Thomas G. Wiggans
Thomas G. Wiggans CEO @ Pardes Biosciences
CEO
2022-03-01

Founder

uri-lopatin_image

Uri Lopatin

Stock Details

Company's stock symbol is NASDAQ:PRDS

Investors List

t-rowe-price_image

Key Employee Changes

Date	New article
2022-03-02	Pardes Biosciences Appoints Thomas G. Wiggans to CEO and Chairman of the Board
2021-11-30	Pardes Biosciences Appoints New Chief Business and Strategy Officer

Official Site Inspections

http://www.pardesbio.com Semrush global rank: 3.57 M Semrush visits lastest month: 4.07 K

Host Informations
Whois Informations

Loading ...